NASDAQ · CNXU
Conexeu Sciences Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for CNXU has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Oct 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Jan 2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Apr 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Jul 2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · MarketBeat- RTTNews · Oct 6, 9:45 AM EDTConexeu Sciences Targets Q1 2027 FDA 510(k) Submission For Ten Minute Tissue(RTTNews) – Conexeu Sciences Inc. (CNXU) said it is advancing manufacturing scale-up, regulatory testing and preclinical work supporting a planned FDA 510(k) submission for Ten Minute Tissue, its lead wound care device candidate.
- RTTNews · Jul 15, 11:41 PM EDTTop Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data(RTTNews) – Today's biotech movers include Apollomics following its return to Nasdaq compliance, Iovance and AVITA ahead of Q2 earnings updates, Annexon, awaiting topline data in dry age-related macular degeneration with geographic atrophy, and Veradermics after reporting positiv
- RTTNews · Jul 8, 3:47 AM EDTConexeu Sciences Targets Tissue Restoration Gap Amid $190 Billion Weight-Loss Boom(RTTNews) – Conexeu Sciences Inc. (CNXU), a preclinical-stage biotechnology company, announced the completion of its 12-month P.R.O.O.F study (Performance and Regeneration Outcomes of Flowable Collagen), supporting the development of its CXU tissue-restoration platform. The progr
- RTTNews · Jun 16, 11:02 PM EDTTop Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212(RTTNews) – Tuesday's top gainers include CervoMed, with key clinical trial catalysts ahead; Conexeu, which strengthened its leadership with board expansion; NeOnc, advancing its lead drug candidate into Phase 2 for aggressive brain tumours; and Simulations Plus, which is set to
- MarketBeat · Jun 4, 10:50 AM EDTBefore the IPO: 4 Companies That Rewarded Investors Who Got In EarlyThe SpaceX (NASDAQ: SPCX) IPO is the most talked-about market event in years. But Chris Graebe, an analyst at Weiss Ratings, says the investors who will really profit already got in—and it wasn't recently. Graebe has spent the last several years guiding everyday investors into p
- RTTNews · Jun 1, 11:07 PM EDTTop Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch(RTTNews) – Monday's top gainers include Turn Therapeutics following its interim analysis findings from an atopic dermatitis study; Conexeu Science on progress in its B.R.E.A.S.T. bioprinting program; LIXTE Biotechnology and its strategic transformation; and Quanterix amid inside
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Conexeu Sciences Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.